US4286057A - Method and reagent for the determination of creatine kinase - Google Patents

Method and reagent for the determination of creatine kinase Download PDF

Info

Publication number
US4286057A
US4286057A US06/125,381 US12538180A US4286057A US 4286057 A US4286057 A US 4286057A US 12538180 A US12538180 A US 12538180A US 4286057 A US4286057 A US 4286057A
Authority
US
United States
Prior art keywords
millimoles
improvement
per liter
micromoles
luciferase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US06/125,381
Other languages
English (en)
Inventor
Karl Wulff
Fritz Stahler
Wolfgang Gruber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Assigned to BOEHRINGER MANNHEIM GMBH, A WEST GERMAN CORP. reassignment BOEHRINGER MANNHEIM GMBH, A WEST GERMAN CORP. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: WULFF KARL, GRUBER WOLFGANG, STAHLER FRITZ
Application granted granted Critical
Publication of US4286057A publication Critical patent/US4286057A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/50—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving creatine phosphokinase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Definitions

  • the invention relates to a method and a reagent for the photometric determination of the activity of creatine phosphokinase (E.C. 2.7.3.2), hereinafter called CK, by means of the bioluminescent system of fireflies.
  • CK creatine phosphokinase
  • the sub-units M and B In the human body, two different kinds of sub-units of this enzyme occur, the sub-units M and B. Since the active enzyme is composed of two sub-units, and since the two sub-units can combine freely with one another, three types of enzyme are possible, the muscle type (CK-MM), the brain type (CK-BB) and the hybrid type (CK-MB), which occurs almost exclusively in the myocardium and enters into the serum in myocardial infarction, where it can be measured in an increased concentration. The activity of this isoenzyme, in addition to the total activity of CK in the serum, is of great importance in the diagnosis of myocardial infarction.
  • CK activity is commonly determined by an absorption photometry method in which the formation of ATP (cf. Equation 1) is measured in the following manner: ##STR2##
  • the light that is produced in this reaction is emitted with a yield of virtually 1 Einstein per mole of ATP. It has a wavelength of 562 nm at the peak.
  • the reaction is extremely sensitive, and permits the quantitative determination of ATP concentrations down to 10 -13 moles per liter.
  • the recovered CK activity with respect to an internal calibration with ATP, amounts to only about 11% of the values measured by the absorption photometry test.
  • the present invention is addressed to the problem of creating a bioluminescent test method for the determination of CK activity, which will not have these disadvantages, and in which especially:
  • the adenylate kinases can be completely inhibited
  • the activity measured by means of bioluminescence expressed in I.U. is equal to the activity measured in the mixture used in the absorption photometry
  • the procedure can be performed with the CK saturated with the substrate.
  • the process of the invention is performed at a pH between 6.3 and 7.2, especially preferably between pH 6.5 and 6.9.
  • the ADP concentration per test amounts preferably to 0.1 to 10 millimoles per liter; the concentration of diadenosine pentaphosphate (Ap5A) amounts preferably to 1 to 100 micromoles per liter.
  • sulfohydryl compounds are, for example, N-acetylcysteine, dithiothreitol, dithioerythritol, and reduced glutathione. N-acetylcysteine is used preferentially.
  • a sequestering agent such as ethylene diamine tetraacetic acid (EDTA), Trilone, Komplexone, Sequestrene and the like.
  • stabilizers such as serum albumin, in amounts familiar to the technician for the stabilization of enzymatic reagents.
  • the AMP which is added in accordance with the invention for the inhibition of the adenylate kinases so modifies the properties of the firefly luciferase under the stated conditions, that the product inhibition by oxyluciferin which usually occurs in the course of the reaction is eliminated.
  • the result is that, when a defined ATP concentration is measured, instead of the flash-like signal-time curve, as heretofore, a substantial constancy of signal over more than 15 minutes is achieved.
  • FIG. 1 shows the constancy of signal achieved in accordance with the invention. It was achieved with the following test mixture:
  • Additional subject matter of the invention is a reagent for the determination of creatine kinase.
  • This reagent is characterized by containing 10 to 500 micromoles of luciferin, at least 50 units of luciferase, 5 to 250 millimoles of buffer, pH 5.8 to 7.5, 1 to 10 millimoles of AMP, 0.1 to 10 millimoles of ADP, 1 to 100 micromoles of diadenosine pentaphosphate, 5 to 50 millimoles of creatine phosphate, 1 to 100 millimoles organic sulfohydryl compound, 0.1 to 5 millimoles of sequestering agent, 0.05 to 1 wt.-% of bovine serum albumin and 1 to 100 millimoles of magnesium ions per liter of test solution. It can be in solid or dissolved form.
  • the reagent of the invention contains 15 to 50 micromoles of luciferin, 1000 to 5 ⁇ 105 units of luciferase, 60 to 120 millimoles of buffering substance, pH 6.3 to 7.2, 5 to 10 millimoles of AMP, 0.5 to 2 millimoles of ADP, 5 to 50 micromoles of diadenosine pentaphosphate, 20 to 40 millimoles of creatine phoshate, 2 to 50 millimoles of organic sulfohydryl compound, 0.5 to 3 millimoles of sequestering agent, 0.05 to 0.2 wt.-% of bovine serum albumin, and 5 to 20 millimoles of magnesium ions, for each liter of test solution.
  • the reagent of the invention preferably contains EDTA, and it contains N-acetylcysteine as the preferred sulfohydryl compound.
  • buffer substances are tris-acetate, imidazole acetate, hepes as acetate, hepes as sulfate or chloride, tris imidazol, tra as sulfate or chloride, arsenate or phosphate buffer.
  • Glycine buffer is also suitable in the stated range. Imidazole acetate and hepes acetate are used perferentially.
  • the concentrations given relate to the prepared reagent solution used in the test; the quantities indicate the amount needed for the preparation of one liter of test solution.
  • a firefly luciferase was used which was isolated by the method described in FEBS-Lett. 70, 167 to 170 (1976).
  • the luciferin was in each case a commercially available product of the highest purity obtainable, such as for example Sigma lots 58C-0349 and 98C-3942, or Calbiochem lot 540022. Other luciferin preparations of comparable purity are likewise suitable.
  • the luciferase units specified hereinbelow were determined as follows:
  • the measurement was performed in a commercial ATP photometer (Mfr., SAI, San Diego, Calif., U.S.A.)
  • the enzyme unit is the amount which under the above-described conditions gives a signal of 37 pulses in ten seconds, the sensitivity potentiometer on the above apparatus being set at 6.7.
  • the mixture is preincubated at 25° C. for 5 minutes, and then the test glass is placed in the measuring instrument (SAI Photometer), and the reaction is started by adding 200 microliters of solution 3, which has also been preincubated at 25° C.
  • the curve is traced on a recorder and, after about 2 minutes the internal calibration of micromoles of substrate transformation per minute is performed with 20 microliters of Solution 4.
  • the results are automatically traced by a recorder.
  • the curve is traced for an additional 2 or 3 minutes to obtain a graph that is easy to analyze, and which is shown in FIG. 2 of the appended drawing.
  • the linearly rising curve gives the rate of rise in arbitrary scale divisions per minute, and the calibration stage permits the conversion of scale divisions (entered as ⁇ mV) in micromoles of ATP.
  • the curve obtained by the conversion is represented in FIG. 3 of the drawing.
  • Test kit for 100 tests For 100 tests.
  • Bottle 1 contains:
  • Bottle 2 contains:
  • Bottle 3 contains:
  • Bottle 4 contains:
  • bottle 1 The content of bottle 1 is dissolved in 100 ml of water, those of bottle 2 in 60 ml of water, those of bottle 3 in 20 ml of water and those of bottle 4 in 2 ml of water for the preparation of ready-to-use solutions.
  • the test is performed as in Example 1, using the amounts of the individual solutions which are given in Example 1.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
US06/125,381 1979-03-02 1980-02-28 Method and reagent for the determination of creatine kinase Expired - Lifetime US4286057A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19792908054 DE2908054A1 (de) 1979-03-02 1979-03-02 Verfahren und reagenz zur bestimmung der creatinkinase
DE2908054 1979-03-02

Publications (1)

Publication Number Publication Date
US4286057A true US4286057A (en) 1981-08-25

Family

ID=6064230

Family Applications (1)

Application Number Title Priority Date Filing Date
US06/125,381 Expired - Lifetime US4286057A (en) 1979-03-02 1980-02-28 Method and reagent for the determination of creatine kinase

Country Status (6)

Country Link
US (1) US4286057A (de)
EP (1) EP0015437B1 (de)
JP (2) JPS585678B2 (de)
AT (1) ATE435T1 (de)
DE (2) DE2908054A1 (de)
FI (1) FI69641C (de)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357420A (en) * 1981-04-28 1982-11-02 The United States Of America As Represented By The United States Department Of Energy Bioluminescence methods for enzymatic determinations
US4547461A (en) * 1983-01-18 1985-10-15 Eastman Kodak Company Composition, analytical element and method for the quantification of creatine kinase
US4704355A (en) * 1985-03-27 1987-11-03 New Horizons Diagnostics Corporation Assay utilizing ATP encapsulated within liposome particles
US4767699A (en) * 1985-05-02 1988-08-30 Allied Corporation Diagnostic reagent, kit and method employing polynucleotide displacement, separation, enzymatic cleavage and adenosine phosphate detection
US5283180A (en) * 1990-07-19 1994-02-01 Charm Sciences, Inc. Bioluminescence method for the determination of pesticides
US5374534A (en) * 1990-07-19 1994-12-20 Charm Sciences, Inc. Method of preparing D-luciferin derivatives
US5817467A (en) * 1995-11-16 1998-10-06 Kyowa Medex Co., Ltd. Method for quantitatively determining creatinine kinase and a reagent therefor
US5866348A (en) * 1993-02-10 1999-02-02 Parkard Instrument Company, Inc. Bioluminescence measurement system
US6171809B1 (en) 1998-01-29 2001-01-09 Packard Instrument Company Method and compositions for detecting luciferase biological samples
US20040063165A1 (en) * 2000-12-15 2004-04-01 Gawad Yahia A. Light-activated in vitro assay process for luciferase bioluminescence
US20040077030A1 (en) * 2000-12-15 2004-04-22 Lumitech (Uk) Limited Methods and kits for detecting protein kinases
US20090136976A1 (en) * 2006-08-02 2009-05-28 Industrial Technology Research Institute Luminescence-based composition

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1175737A (en) * 1981-07-17 1984-10-09 James A. Sanderson Determination of creatine phosphokinase in body fluids
JPS60168488U (ja) * 1984-04-13 1985-11-08 飯島　敏子 洗濯用袋
CA1251395A (en) * 1985-05-01 1989-03-21 John B. Findlay Immunochemical method and analytical compositions and element for determination of creatine kinase-mb
JP2564295B2 (ja) * 1987-03-23 1996-12-18 エーザイ株式会社 ビタミンｅ欠乏症の検査のためのピルビン酸キナーゼ活性の測定方法
US4981708A (en) * 1989-10-02 1991-01-01 Enzytech, Inc. Method of preventing browning in foods utilizing protease free latex extracts particularly from figs
US5734546A (en) * 1994-09-21 1998-03-31 Rohm Co. Ltd. Capacitor element for solid electrolytic capacitor and process for making the same
KR20060014025A (ko) 2003-02-26 2006-02-14 가부시키가이샤 시마세이키 세이사쿠쇼 위편기의 얀 캐리어

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3575811A (en) * 1968-10-23 1971-04-20 Hazleton Lab Inc Method for the detection of cancer
US4080265A (en) * 1974-08-02 1978-03-21 Antonik Alan S Method for the determination of creative phosphokinase enzyme

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3423290A (en) * 1966-08-03 1969-01-21 Nasa Lyophilized reaction mixtures
DE2302721C2 (de) * 1973-01-19 1975-01-23 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Bestimmung der Creatinkinase
US4001088A (en) * 1974-08-02 1977-01-04 Antonik Alan S Method for the determination of creatine phosphokinase enzyme
DE2828658C3 (de) * 1978-06-29 1981-10-22 Lkb-Produkter Ab, Stockholm Verfahren zur photometrischen Bestimmung der Untereinheit B der Creatinkinase und Reagens hierfür

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3575811A (en) * 1968-10-23 1971-04-20 Hazleton Lab Inc Method for the detection of cancer
US4080265A (en) * 1974-08-02 1978-03-21 Antonik Alan S Method for the determination of creative phosphokinase enzyme

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Gates B. J. et al.; Archives of Biochemistry and Biophysics; vol. 169, pp. 616-621, (1975). *
Lee R. T. et al.; Archives of Biochemistry and Biophysics, vol. 141, pp. 38-52; (1970). *
Lundin A. et al.; Clinica Chimica Acta, vol. 87, pp. 199-209, (1978). *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357420A (en) * 1981-04-28 1982-11-02 The United States Of America As Represented By The United States Department Of Energy Bioluminescence methods for enzymatic determinations
US4547461A (en) * 1983-01-18 1985-10-15 Eastman Kodak Company Composition, analytical element and method for the quantification of creatine kinase
US4704355A (en) * 1985-03-27 1987-11-03 New Horizons Diagnostics Corporation Assay utilizing ATP encapsulated within liposome particles
US4767699A (en) * 1985-05-02 1988-08-30 Allied Corporation Diagnostic reagent, kit and method employing polynucleotide displacement, separation, enzymatic cleavage and adenosine phosphate detection
US5374535A (en) * 1990-07-19 1994-12-20 Charm Sciences, Inc. Test kit for determination of organophosphate and carbamate pesticides with insect brain material that hydrolyses a 6-substituted d luciferin ester
US5374534A (en) * 1990-07-19 1994-12-20 Charm Sciences, Inc. Method of preparing D-luciferin derivatives
US5283180A (en) * 1990-07-19 1994-02-01 Charm Sciences, Inc. Bioluminescence method for the determination of pesticides
US5866348A (en) * 1993-02-10 1999-02-02 Parkard Instrument Company, Inc. Bioluminescence measurement system
US5817467A (en) * 1995-11-16 1998-10-06 Kyowa Medex Co., Ltd. Method for quantitatively determining creatinine kinase and a reagent therefor
US6171809B1 (en) 1998-01-29 2001-01-09 Packard Instrument Company Method and compositions for detecting luciferase biological samples
US20040063165A1 (en) * 2000-12-15 2004-04-01 Gawad Yahia A. Light-activated in vitro assay process for luciferase bioluminescence
US20040077030A1 (en) * 2000-12-15 2004-04-22 Lumitech (Uk) Limited Methods and kits for detecting protein kinases
US20040253658A1 (en) * 2000-12-15 2004-12-16 Lumitech (Uk) Limited Methods and kits for detecting protein kinases
US6911319B2 (en) 2000-12-15 2005-06-28 Lumitech (Uk) Limited Methods and kits for detecting protein kinases
US20090136976A1 (en) * 2006-08-02 2009-05-28 Industrial Technology Research Institute Luminescence-based composition

Also Published As

Publication number Publication date
FI69641C (fi) 1986-03-10
JPS55120796A (en) 1980-09-17
EP0015437A1 (de) 1980-09-17
JPS57105199A (en) 1982-06-30
ATE435T1 (de) 1981-12-15
JPS615720B2 (de) 1986-02-20
DE3060087D1 (en) 1982-01-28
FI800578A (fi) 1980-09-03
FI69641B (fi) 1985-11-29
JPS585678B2 (ja) 1983-02-01
DE2908054A1 (de) 1980-09-11
EP0015437B1 (de) 1981-11-25

Similar Documents

Publication Publication Date Title
US4286057A (en) Method and reagent for the determination of creatine kinase
US4235961A (en) Method for photometric determination of the subunit B of creatine kinase and a reagent for carrying out the method
Estabrook et al. A fluorimetric method for the quantitative microanalysis of adenine and pyridine nucleotides
Lust et al. The enzymatic measurement of adenine nucleotides and P-creatine in picomole amounts
US4246340A (en) Method and reagent for bioluminiscence
GB1512328A (en) Method and reagent for determining the activity of creatinekinase-mb
Lundin et al. Sensitive assay of creatine kinase isoenzymes in human serum using M subunit inhibiting antibody and firefly luciferase
Hørder et al. Recommended method for the determination of creatine kinase in blood modified by the inclusion of EDTA: The Committee on Enzymes of The Scandinavian Society for Clinical Chemistry and Clinical Physiology (SCE)
Marcus et al. Studies on Bovine Hepatic Fructose 1, 6-Diphosphatase: SUBSTRATE INHIBITION AND THE KINETIC MECHANISM
Dyson et al. A rapid pH-stat assay for phosphofructokinase and the forward reaction of phosphoglucose isomerase
Hess et al. Pyruvate kinase from yeast
Fu et al. Activation of muscle fructose 1, 6-diphosphatase by creatine phosphate and citrate
Gamble Jr et al. Intramitochondrial metabolism of phosphoenolpyruvate
El-Badry et al. Studies on heart phosphofructokinase: role of fructose 1, 6-diphosphate in enzyme activity
Holmsen et al. The adenosine triphosphate inhibition of the pyruvate kinase reaction and its dependence on the total magnesium ion concentration
Gelb et al. Unusual kinetic transition in honeybee glyceraldehyde phosphate dehydrogenase
Bornmann et al. Interaction of Cibacron dyes with dehydrogenases and kinases
US4888289A (en) Reagent for determining creatine kinase
US5817467A (en) Method for quantitatively determining creatinine kinase and a reagent therefor
EP0022432B1 (de) Verfahren zur Bestimmung der Creatinkinase
Melnick et al. Measurement of mitochondrial oxidative phosphorylation: Selective inhibition of adenylate kinase activity by P1, P5-di-(adenosine-5′)-pentaphosphate
US6413733B1 (en) Stabilized reagent and method for determining creatine kinase
Rhee et al. Fluorometric studies of aza-epsilon-adenylylated glutamine synthetase from Escherichia coli.
Gruber et al. Analytical Differentiation of Purine and Pyrimidine Nucleotides Determination of ADP, ATP, and Sum of GTP+ ITP in Biological Material
US5250416A (en) Method for highly sensitive determination of NADH using kinase

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: BOEHRINGER MANNHEIM GMBH, SANDHOFER STRASSE 112-13

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:WULFF KARL;STAHLER FRITZ;GRUBER WOLFGANG;REEL/FRAME:003885/0887;SIGNING DATES FROM 19800221 TO 19800226